Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment of moderately active ulcerative colitis in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback